photo of

Details

Role Group Leader / Honorary Fellow Manager
Professor Suzanne Garland is the Group Leader of the Molecular Microbiology group at MCRI.
Professor Suzanne Garland is the Group Leader of the Molecular Microbiology group at MCRI.

Top Publications

  • Templeton, DJ, Roberts, JM, Poynten, IM, Law, C, Hillman, RJ, Farnsworth, A, Fairley, CK, Tabrizi, SN, Garland, SM, Grulich, AE, et al. Prevalence and predictors of unsatisfactory anal cytology tests in a cohort of gay and bisexual men in Sydney, Australia. European Journal of Cancer Prevention 26(3) : 212 -216 2017
    view publication
  • Murray, GL, Bradshaw, CS, Bissessor, M, Danielewski, J, Garland, SM, Jensen, JS, Fairley, CK, Tabrizi, SN. Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium. Emerging Infectious Diseases 23(5) : 809 -812 2017
    view publication
  • Lee, L, Garland, SM, Giles, ML, Daley, AJ. Manipulating the baby biome: What are the issues?. Australian and New Zealand Journal of Obstetrics and Gynaecology 57(2) : 232 -234 2017
    view publication
  • Toh, ZQ, Russell, FM, Reyburn, R, Fong, J, Tuivaga, E, Ratu, T, Nguyen, CD, Devi, R, Kama, M, Matanitobua, S, et al. Sustained Antibody Responses 6 Years Following 1, 2, or 3 Doses of Quadrivalent Human Papillomavirus (HPV) Vaccine in Adolescent Fijian Girls, and Subsequent Responses to a Single Dose of Bivalent HPV Vaccine: A Prospective Cohort Study. Clinical Infectious Diseases 64(7) : 852 -859 2017
    view publication
  • Cornall, AM, Poljak, M, Garland, SM, Phillips, S, Tan, JH, Machalek, DA, Quinn, MA, Tabrizi, SN. Anyplex II HPV28 detection and Anyplex II HPV HR detection assays are highly concordant with other commercial assays for detection of high-risk HPV genotypes in women with high grade cervical abnormalities. European Journal of Clinical Microbiology & Infectious Diseases 36(3) : 545 -551 2017
    view publication